Skip to main content
. Author manuscript; available in PMC: 2016 Oct 31.
Published in final edited form as: Mil Med. 2016 Apr;181(4):334–342. doi: 10.7205/MILMED-D-15-00110

TABLE 3.

Characteristics associated with the odds of a positive drug test, postdeployment follow-up window (6 mo to 3 yr), US Army enlisted personnel by component, Substance Use and Psychological Injury Combat Study

Characteristica Multivariate Logistic Model
Adjusted Odds Ratiob (95% CI)
Active Duty Enlisted
N=306,345
National Guard/Reserve Enlisted
N=136,433

Demographic

Gender
 Female (ref.) 1.0 1.0
 Male 2.27 (2.05–2.51)* 1.98 (1.76–2.23)*

Age
 17–24 (ref.) 1.0 1.0
 25–29 0.69 (0.65–0.73)* 0.74 (0.68–0.81)*
 30–39 0.36 (0.32–0.39)* 0.41 (0.37–0.45)*
 40+ 0.21 (0.16–0.26)* 0.31 (0.27–0.36)*

Race
 White (ref.) 1.0 1.0
 Black 1.71 (1.61–1.81)* 2.01 (1.86–2.17)*
 Asian/Pacific Islander 1.14 (1.07–1.22)* 0.75 (0.60–0.92)*
 Other/unknown 0.82 (0.70–0.96)* 0.98 (0.79–1.21)

Hispanic ethnicity
 No (ref.) 1.0 1.0
 Yes 0.93 (0.87–1.01) 0.94 (0.83–1.06)

Marital status
 Married/divorced/other (ref.) 1.0 1.0
 Never married 1.15 (1.09–1.22)* 1.66 (1.53–1.81)*

Any child dependent receiving TRICARE benefits
 No (ref.) 1.0 1.0
 Yes 1.08 (1.02–1.16)* 1.13 (1.04–1.23)*

Education level
 College degree (ref.) 1.0 1.0
 Less than college degree 2.96 (2.29–3.81)* 4.23 (3.06–5.84)*

DoD occupation
 Other occupation (ref.) 1.0 1.0
 Combat specialist 1.17 (1.11–1.23)* 1.43 (1.34–1.52)*

Deployment

Fiscal year of begin date of index deployment
 FY2007 or earlier 10.44 (8.09–13.48)* 4.04 (3.34–4.87)*
 FY2008 8.54 (6.64–10.99)* 4.16 (3.48–4.96)*
 FY2009 5.47 (4.26–7.03)* 3.39 (2.86–4.02)*
 FY2010 2.27 (1.76–2.92)* 1.56 (1.30–1.86)*
 FY2011 (ref.) 1.0 1.0

Length of index deployment (months)
 1–11 (ref.) 1.0 1.0
 12 0.87 (0.82–0.92)* 0.93 (0.80–1.08)
 >12 0.80 (0.75–0.86)* 0.67 (0.57–0.80)*

Dwell time under 12 months
 No (ref.) 1.0 1.0
 Yes 1.12 (0.97–1.29) 1.55 (1.22–1.97)*
 No prior deployment 1.97 (1.85–2.09)* 2.28 (2.09–2.50)*

Assigned to Warrior Transition Unit since start of index deployment
 No (ref.) 1.0 1.0
 Yes 1.63 (1.47–1.80)* 1.10 (0.95–1.28)
a

Characteristic measured at beginning of FY2008–2011 index deployment, unless indicated.

b

Models also control for number of specimens tested, number of months between the ending of the index deployment and the last collection date, and region of residence.

CI = 95% confidence interval

*

Wald Chi-Square Test, p<0.05